Literature DB >> 20031538

Genome-wide association analysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.

Iris M Heid1, Eva Boes, Martina Müller, Barbara Kollerits, Claudia Lamina, Stefan Coassin, Christian Gieger, Angela Döring, Norman Klopp, Ruth Frikke-Schmidt, Anne Tybjaerg-Hansen, Anita Brandstätter, Andreas Luchner, Thomas Meitinger, H-Erich Wichmann, Florian Kronenberg.   

Abstract

BACKGROUND: High-density lipoprotein cholesterol (HDLC) is a strong risk factor for atherosclerosis and is assumed to be under considerable genetic control. We aimed to identify gene regions that influence HDLC levels by a genome-wide association analysis in the population-based KORA (Cooperative Health Research in the Region of Augsburg) study. METHODS AND
RESULTS: In KORA S3/F3 (n=1643), we analyzed 377 865 quality-checked single-nucleotide polymorphisms (SNPs; 500K, Affymetrix, Santa Clara, Calif), complemented by the publicly available genome-wide association results from the Diabetes Genetics Initiative (n=2631) and by replication data from KORA S4 (n=4037) and the Copenhagen City Heart Study (n=9205). Among the 13 SNPs selected from the KORA S3/F3 500K probability value list, 3 showed consistent associations in subsequent replications: 1 SNP 10 kb upstream of CETP (pooled probability value=8.5x10(-27)), 1 SNP approximately 40 kb downstream of LIPG (probability value=4.67x10(-10)), both independent of previously reported SNPs, and 1 from an already reported region of LPL (probability value=2.82x10(-11)). Bioinformatical analyses indicate a potential functional relevance of the respective SNPs.
CONCLUSIONS: The present genome-wide association study identified 2 interesting HDLC-relevant regions upstream of CETP and downstream of LIPG. This draws attention to the importance of long-range effects of intergenic regions, which have been underestimated so far, and may impact future candidate-gene-association studies toward extending the region analyzed. Furthermore, the present study reinforced CETP and LPL as HDLC genes and thereby underscores the power of this type of genome-wide association approach to pinpoint associations of common polymorphisms with effects explaining as little as 0.5% of the HDLC variance in the general population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20031538     DOI: 10.1161/CIRCGENETICS.108.776708

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  50 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

2.  Resequencing of the CETP gene in American whites and African blacks: Association of rare and common variants with HDL-cholesterol levels.

Authors:  Dilek Pirim; Xingbin Wang; Vipavee Niemsiri; Zaheda H Radwan; Clareann H Bunker; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  Metabolism       Date:  2015-09-30       Impact factor: 8.694

3.  Implications of discoveries from genome-wide association studies in current cardiovascular practice.

Authors:  Panniyammakal Jeemon; Kerry Pettigrew; Christopher Sainsbury; Dorairaj Prabhakaran; Sandosh Padmanabhan
Journal:  World J Cardiol       Date:  2011-07-26

4.  Relation of lipid gene scores to longitudinal trends in lipid levels and incidence of abnormal lipid levels among individuals of European ancestry: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Pamela L Lutsey; Laura J Rasmussen-Torvik; James S Pankow; Alvaro Alonso; Derek J Smolenski; Weihong Tang; Josef Coresh; Kelly A Volcik; Christie M Ballantyne; Eric Boerwinkle; Aaron R Folsom
Journal:  Circ Cardiovasc Genet       Date:  2011-11-04

5.  Lipoprotein lipase gene sequencing and plasma lipid profile.

Authors:  Dilek Pirim; Xingbin Wang; Zaheda H Radwan; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Lipid Res       Date:  2013-11-09       Impact factor: 5.922

6.  Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.

Authors:  Andrew C Edmondson; Robert J Brown; Sekar Kathiresan; L Adrienne Cupples; Serkalem Demissie; Alisa Knodle Manning; Majken K Jensen; Eric B Rimm; Jian Wang; Amrith Rodrigues; Vaneeta Bamba; Sumeet A Khetarpal; Megan L Wolfe; Stephanie Derohannessian; Mingyao Li; Muredach P Reilly; Jens Aberle; David Evans; Robert A Hegele; Daniel J Rader
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

Review 7.  Emerging risk factors and markers of chronic kidney disease progression.

Authors:  Florian Kronenberg
Journal:  Nat Rev Nephrol       Date:  2009-12       Impact factor: 28.314

Review 8.  Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

Authors:  Eva Boes; Stefan Coassin; Barbara Kollerits; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-11-17       Impact factor: 4.032

9.  Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study.

Authors:  Jing-Ping Lin; Johannes P Schwaiger; L Adrienne Cupples; Christopher J O'Donnell; Gang Zheng; Veit Schoenborn; Steven C Hunt; Jungnam Joo; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2009-03-19       Impact factor: 5.162

10.  A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C.

Authors:  Maria G Stathopoulou; Amélie Bonnefond; Ndeye Coumba Ndiaye; Mohsen Azimi-Nezhad; Said El Shamieh; Abdelsalam Saleh; Marc Rancier; Gerard Siest; John Lamont; Peter Fitzgerald; Sophie Visvikis-Siest
Journal:  J Lipid Res       Date:  2012-12-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.